Cargando…

Management of Cardiac Sarcoidosis in 2020

Sarcoidosis is an inflammatory granulomatous disease that can affect any organ. Up to one-quarter of patients with systemic sarcoidosis may have evidence of cardiac involvement. The clinical manifestations of cardiac sarcoidosis (CS) include heart block, atrial arrhythmias, ventricular arrhythmias a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gilotra, Nisha, Okada, David, Sharma, Apurva, Chrispin, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Radcliffe Cardiology 2020
Materias:	Clinical Arrhythmias
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788397/ https://www.ncbi.nlm.nih.gov/pubmed/33437485 http://dx.doi.org/10.15420/aer.2020.09

Ejemplares similares

The 2020 ESC Guidelines on the Diagnosis and Management of Atrial Fibrillation
por: Kotalczyk, Agnieszka, et al.
Publicado: (2021)

Current State and Future Directions of Multimodality Imaging in Cardiac Sarcoidosis
por: Wand, Alison L., et al.
Publicado: (2022)

Cardiac MRI to Manage Atrial Fibrillation
por: Zhao, Yan, et al.
Publicado: (2020)

Wearable cardioverter defibrillator multicentre experience in a large cardiac surgery cohort at transient risk of sudden cardiac death
por: Kuehn, Christian, et al.
Publicado: (2022)

Applications of Machine Learning in Cardiac Electrophysiology
por: Muthalaly, Rahul G, et al.
Publicado: (2020)

Heart Brake: An Unusual Cardiac Manifestation of COVID-19
por: Kir, Devika, et al.
Publicado: (2020)

Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis
por: Yoshitomi, Ryosuke, et al.
Publicado: (2022)

Sudden Cardiac Death Risk Stratification and Prevention in Chagas Disease: A Non-systematic Review of the Literature
por: Keegan, Roberto, et al.
Publicado: (2020)

Brugada Syndrome: Progress in Diagnosis and Management
por: Pappone, Carlo, et al.
Publicado: (2019)

Prevalence of early repolarization pattern and its association with sudden cardiac death and arrhythmia over one-year follow-up in an Egyptian cohort
por: Abdellah, Ahmed Tageldien, et al.
Publicado: (2018)

Atrial Fibrosis: Translational Considerations for the Management of AF Patients
por: Tzeis, Stylianos, et al.
Publicado: (2019)

Brugada Syndrome: Progress in Genetics, Risk Stratification and Management
por: Romero, Jorge, et al.
Publicado: (2019)

A Review of Driving Restrictions in Patients at Risk of Syncope and Cardiac Arrhythmias Associated with Sudden Incapacity: Differing Global Approaches to Regulation and Risk
por: Margulescu, Andrei D, et al.
Publicado: (2019)

Atrial Tachycardias After Atrial Fibrillation Ablation: How to Manage?
por: Hung, Yuan, et al.
Publicado: (2020)

Risk of out-of-hospital cardiac arrest in patients with sarcoidosis: a Danish nationwide nested case–control study
por: Eroglu, Talip E, et al.
Publicado: (2023)

Obesity and Atrial Fibrillation: Epidemiology, Pathogenesis and Effect of Weight Loss
por: Al-Kaisey, Ahmed M, et al.
Publicado: (2021)

Cardiopulmonary bypass management and risk of new-onset atrial fibrillation after cardiac surgery
por: Taha, Amar, et al.
Publicado: (2023)

Comment on ‘Management of Cardiac Sarcoidosis in 2020’
por: Korovesis, Socrates, et al.
Publicado: (2021)

Sleep Apnoea and AF: Where Do We Stand? Practical Advice for Clinicians
por: Mittal, Suneet, et al.
Publicado: (2021)

Sinus Node Dysfunction in a Young Patient With COVID-19
por: Cimino, Giuliana, et al.
Publicado: (2020)

Transient Brugada-Like Electrocardiographic Pattern in a Patient With COVID-19
por: Vidovich, Mladen I.
Publicado: (2020)

The Known Into the Unknown: Brugada Syndrome and COVID-19
por: Sorgente, Antonio, et al.
Publicado: (2020)

Electrical Storm in COVID-19
por: O’Brien, Connor, et al.
Publicado: (2020)

Idiopathic short-coupled ventricular tachyarrhythmias: Systematic review and validation of electrocardiographic indices
por: Almehairi, Mohammed, et al.
Publicado: (2018)

XANTUS-EL: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Eastern Europe, Middle East, Africa and Latin America
por: Martínez, Carlos Arturo Areán, et al.
Publicado: (2018)

Comment on ‘Leadless Pacemakers: Current Achievements and Future Perspectives’
por: Akhtar, Zaki, et al.
Publicado: (2023)

Leadless Pacemakers: Current Achievements and Future Perspectives
por: Vouliotis, Apostolos Ilias, et al.
Publicado: (2023)

Transvenous Lead Extraction: Work in Progress
por: Akhtar, Zaki, et al.
Publicado: (2023)

Decreased Noise and Identification of Very Low Voltage Signals Using a Novel Electrophysiology Recording System
por: Kautzner, Josef, et al.
Publicado: (2023)

Atrial Myopathy Underlying Atrial Fibrillation
por: Rivner, Harold, et al.
Publicado: (2020)

Differential Diagnosis of Wide QRS Tachycardias
por: Katritsis, Demosthenes G, et al.
Publicado: (2020)

Rhythm Control in Heart Failure Patients with Atrial Fibrillation
por: Eysenck, William, et al.
Publicado: (2020)

Big Data and Artificial Intelligence: Opportunities and Threats in Electrophysiology
por: van de Leur, Rutger R, et al.
Publicado: (2020)

The Cryoballoon vs Irrigated Radiofrequency Catheter Ablation (CIRCA-DOSE) Study Results in Context
por: Andrade, Jason G, et al.
Publicado: (2020)

Non-invasive Low-level Tragus Stimulation in Cardiovascular Diseases
por: Jiang, Yunqiu, et al.
Publicado: (2020)

Frequency and Determinants of Spontaneous Conversion to Sinus Rhythm in Patients Presenting to the Emergency Department with Recent-onset Atrial Fibrillation: A Systematic Review
por: Pluymaekers, Nikki AHA, et al.
Publicado: (2020)

The Atrial Phenotype of the Inherited Primary Arrhythmia Syndromes
por: Conte, Giulio, et al.
Publicado: (2019)

Atrial Fibrillation and Dementia: Exploring the Association, Defining Risks and Improving Outcomes
por: Bunch, T Jared, et al.
Publicado: (2019)

Obesity and Atrial Fibrillation: Epidemiology, Pathophysiology and Novel Therapeutic Opportunities
por: Vyas, Vishal, et al.
Publicado: (2019)

Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells
por: Sala, Luca, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t37ho7jnqv7g6v389ad9s0fvfi